International CML Foundation

Home
United Kingdom
Bexhill
International CML Foundation

Improving outcomes for patients with CML globally. The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally.

Founded by a dedicated group of hematologists, we are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care. We foster international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research. As a charitable foundation with a global reach, we strive to empower physicians, researchers, patients and care

givers alike, in the collective pursuit of a cure. Join us and contribute to a world where a cure for CML is not just a hope, but a reality.

10/06/2026

Attending or following the congress remotely?

The EHA2026 program features important updates across treatment optimisation, treatment-free remission, pediatric CML, disease progression and blast crisis, emerging therapeutic approaches, and translational research.

The iCMLf will help you stay up to date before, during, and after the meeting:

📋 Before the congress
• Download the CML Meeting Schedule and plan your EHA2026 experience:
https://bit.ly/4e3DHpz

📍 During the congress
• Follow iCMLf summaries of key CML scientific highlights and presentations
• Meet Nicola Evans, Chief Executive of the iCMLf, in Stockholm to discuss our programs, collaborations, and opportunities to get involved

🎓 After the congress
• Join our upcoming iCMLf Conversations webinar, "CML Highlights of EHA2026 – discussing key biological and clinical perspectives of the meeting - more details will follow soon

To arrange a meeting with Nicola Evans during EHA2026, please contact [email protected].

We look forward to connecting with members of the global CML community in Stockholm and sharing the key CML highlights from EHA2026.

08/06/2026

📢 Help shape the first clinical recommendations for pediatric CML in low- and middle-income countries

The iCMLf and the I-BFM CML Working Group are developing the first dedicated clinical recommendations for managing pediatric CML in low- and middle-income countries (LMICs).

Already, 31 clinicians from 19 countries across Latin America, Sub-Saharan Africa, South and Central Asia, the Middle East, Eastern Europe, and the Pacific have shared their experiences. The interim findings highlight both strong alignment with international treatment recommendations and the significant challenges many centres face, including limited access to second-generation TKIs, molecular monitoring, and therapeutic drug monitoring.

Find out more about what the latest data reveals: https://buff.ly/4QHVHYJ

To ensure these recommendations reflect the realities of clinical practice across diverse resource settings, we need to hear from more physicians treating children and adolescents with CML in LMICs.

📝 The survey takes approximately 15–20 minutes to complete.
👉 Complete the survey: https://buff.ly/HsNX7D3

Please help us strengthen this important initiative by participating and sharing the survey with colleagues who manage pediatric CML patients in LMICs.

05/06/2026

📢 Join the International CML Foundation (iCMLf) Team

Are you a communications professional looking to use your skills to make a meaningful impact in global health?

We are looking for an experienced communications team member to join the iCMLf
and lead content creation, editing and publishing across our communication
channels for the iCMLf global programs.

📍 Part-time (3 days per week)
📍 Fully remote
📍 Global applications welcome

The Communications Manager is a key role within iCMLf’s communications team, bringing our stories and data to life with engaging and effective writing and content design.

This fully remote role offers the opportunity to work with a small global team, creating engaging content across digital channels and helping bring our mission to life for people with CML around the world.

If you have experience in communications, content creation, digital engagement, and enjoy translating complex topics into compelling stories, we'd love to hear from you.

To apply, please send your CV and cover letter to Nicola Evans, Chief Executive:
[email protected]

Learn more about the role here: https://buff.ly/ZvdpEiR

04/06/2026

Latin America CML Physicians - Join the Discussion!

The iCMLf Regional Discussion Group Meetings 2026 are underway. Connect with CML experts and colleagues across Latin America to explore key challenges in treatment and patient care.

📅 Third session: July 2nd
📌 Topic:
✅ How to get the best out of the CML laboratory

⏰ Start times:
Mexico City – 17:00
Bogotá – 18:00
Santiago - 19:00
Buenos Aires / Rio de Janeiro – 20:00

🌎 Online | Open to physicians and scientists working on CML across Latin America
🗣 Spanish interpretation available

🔗 Register now: https://buff.ly/ra8354m

03/06/2026

Here is our selection of CML Papers for May curated by Professor Timothy Hughes:

1️⃣ From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia
Hochhaus A et al. Leukemia, May 2026 (epub ahead of print)
Open access publication
https://buff.ly/cmGHC1H

2️⃣ Assessment of transitioning from high-potency to low-potency inhibitors in chronic myeloid leukemia (CML) patients: The downgrading-impact (D-IMPACT) project
Abruzzese E et al. Cancers(Basel), May 2026
Open access publication
https://buff.ly/BAvdNp2

3️⃣ High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression
Li L et al. Blood, May 2026
https://buff.ly/3Mj5ShO

4️⃣ Therapeutic drug monitoring of imatinib in pediatric chronic myeloid leukemia:
Towards practical implementation and interpretation of measured plasma concentrations
Lenker P et al. Clin Pharmacokinet, May 2026 (epub ahead of print)
Open access publication
https://buff.ly/37eIDkc

5️⃣ Impact of the changes in chronic myeloid leukemia classification proposed by the 2022 World Health Organization: a single-center Brazilian study
Emiliano EG et al. Hematol Transfus Cell Ther, May 2026 (epub ahead of print)
Open access publication
https://buff.ly/AB3Jqa9

📖 Explore the full list of papers on our website: https://buff.ly/vMHl5xh

02/06/2026

Tomorrow. Online. Expert CML discussion - for physicians in Saudi Arabia. 🇸🇦

The first iCMLf Regional Discussion Group Saudi Arabia takes place tomorrow with Professors Dennis Kim and Jorge Cortes alongside Dr Ayel Yahya and Professor Naeem Chaudhri discussing dose reduction pathways to TFR and second and subsequent TFR attempts.

If you treat CML patients in Saudi Arabia, this conversation is for you.

⏱️ Wednesday, June 3rd on Zoom at 20.00 in Saudi Arabia

Register now: https://buff.ly/jrSiafk

With thanks to for their sponsorship of this event.

29/05/2026

25 years of TKI therapy in CML – from revolution to reality

A new CancerWorld special issue celebrates 25 years of tyrosine kinase inhibitor therapy in CML, bringing together perspectives from across the global CML community.

The iCMLf is pleased to contribute the article “From Revolution to Reality”, reflecting on how scientific advances, education, global collaboration, patient advocacy, and improved access to treatment have transformed CML management worldwide.

While remarkable progress has been made, the article also looks ahead to the next challenge: ensuring equitable access to high-quality treatment for all patients and moving beyond disease control towards treatment-free remission and, ultimately, cure.

📖 Read the special issue and explore the iCMLf contribution here: https://buff.ly/0yLhOHu

28/05/2026

Today is WorldBloodCancerDay - a reminder that progress in CML depends on global collaboration and access to education and reliable information.

The iCMLf works to improve the lives of people with CML by educating and supporting physicians treating CML, especially in regions where access to resources may be limited.

Through the iCMLf Resource Hub, physicians and scientists can access practical CML resources, expert insights, educational materials, and tools to support patient management worldwide.

Explore the Resource Hub: https://buff.ly/cDAoqb0

27/05/2026

🇸🇦 Reminder: Saudi Arabian CML Physicians – Join the Discussion!

There is still time to register for the inaugural iCMLf Regional Discussion Group Meeting for Saudi Arabia.

Join physicians and scientists working in CML from across the country for an interactive online discussion with regional and international experts.

📅 June 3rd, 2026
🕗 20:00 Saudi Arabia time
💻 1.5-hour online meeting

Discussion topics:
• Dose reduction as a pathway to treatment-free remission
• Second and subsequent treatment-free remission attempts

Don’t miss this opportunity to exchange experiences, discuss real-world practice, and connect with colleagues across Saudi Arabia.

Register here: https://buff.ly/qrDa0oK

21/05/2026

📢 Last chance to submit your abstract for

The abstract submission deadline for the ESH-iCMLf 28th Annual John Goldman Conference on Chronic Myeloid Leukemia: Biology and Therapy is tomorrow, May 22, 2026, at 23:59 CEST.

Join leading CML experts in Gothenburg from October 2–4, 2026, and contribute to the scientific programme. Abstracts are eligible for oral or poster presentation.

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause
Co-organizers: R. Bhatia, T. Brümmendorf, M. Copland, M. Deininger, O. Hantschel, V. Helgason, S. T. Ong, J. Radich, D. Réa

Submit your abstract here: https://us.list-manage.com/DpyUzXHqct0?e=137f9c0358&c2id=cf5c6f8e7d81bf2de624bb88c946edea

Address

Bexhill

Website

http://www.cml-foundation.org/

Alerts

Be the first to know and let us send you an email when International CML Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Bexhill?